F. Malnique, “COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT”, Editora, pp. 316–330, Nov. 2025, Accessed: Jan. 10, 2026. [Online]. Available: https://sevenpubl.com.br/editora/article/view/8436